Xact Kapitalforvaltning’s Impax Laboratories, Inc. IPXL Stock Holding History

Xact Kapitalforvaltning’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,874	Closed	-$211K	–	1605
2018 Q1	$211K	Sell	10,874 -1,000	-8%	-$19.6K	﹤0.01%	1464
2017 Q4	$198K	Buy	+11,874	New	+$218K	﹤0.01%	1266

Xact Kapitalforvaltning's IPXL Position: Q2 2018 in Review

Xact Kapitalforvaltning sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 10,874 shares — an estimated $211K sold.

Xact Kapitalforvaltning first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $211K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Xact Kapitalforvaltning reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Xact Kapitalforvaltning sold 10,874 Impax Laboratories, Inc. shares in Q2 2018, an estimated $211K.
Xact Kapitalforvaltning first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
Xact Kapitalforvaltning's Impax Laboratories, Inc. position peaked at $211K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Xact Kapitalforvaltning's 13F filing for Q2 2018, filed 11 Jul 2018.